Back to SNY Stock Lookup

SNY Related Analyst Ratings

Apr 3, 2013 09:59 AM Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)

Jan 29, 2013 09:10 AM Barclays Downgrades Sanofi-Aventis (SNY) to Equalweight

Dec 14, 2012 08:52 AM Jefferies Upgrades Sanofi-Aventis (SNY) to Buy

Nov 21, 2012 08:37 AM Investors Willing to Wait on Novartis (NVS) Could Reap Dividends - Barron's

Nov 7, 2012 10:09 AM RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity

Oct 18, 2012 10:51 AM Regeneron (REGN) May See Pressure in U.S. Over Zaltrap Pricing (SNY)

Sep 10, 2012 06:52 AM BofA/Merrill Lynch Upgrades Sanofi-Aventis (SNY) to Buy

Sep 5, 2012 09:31 AM Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Generic Renagel/Renvela Gains Clarity

Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM

Aug 10, 2012 08:38 AM Cowen Upgrades Sanofi-Aventis (SNY) to Outperform

Aug 3, 2012 02:07 PM Standpoint Research Downgrades Sanofi-Aventis (SNY) to Hold; Valuation Call

Jul 31, 2012 08:41 AM Nomura Securities Upgrades TOTAL S.A. (TOT) to Neutral; Increased Probability of Large Disposal Program

Jun 22, 2012 03:34 PM Barclays Reiterates an 'Underweight' on Novo Nordisk (NVO); Shares Trading As If Not Risk Priced In

Jun 13, 2012 10:55 AM Canaccord Genuity Morning Coffee on Sanofi (SNY): Best Words In The English Language: It's Benign

Jun 12, 2012 05:44 PM Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck

Jun 11, 2012 05:17 PM Barclays on Global Biopharma Stocks: American Diabetes Association 2012: Highlights From GSK, LLY, SNY, NVO & JNJ

May 10, 2012 09:13 AM SocGen Starts GSK, NVS, SNY at Buy, AZN at Hold

Apr 4, 2012 09:11 AM Leerink Swann Starts Shire plc (SHPGY) at Market Perform; Growth Already Priced In; Wait for Better Entry

Mar 28, 2012 12:35 PM Analysts Expecting Higher Bids for Amylin (AMLN)

Mar 6, 2012 07:54 AM JPMorgan Upgrades Sanofi-Aventis (SNY) to Overweight

Feb 1, 2012 10:19 AM Goldman Sachs Downgrades Sanofi-Aventis (SNY) to Conviction Sell

Jan 18, 2012 08:03 AM BofA/Merrill Lynch Downgrades Sanofi-Aventis (SNY) to Neutral

Jan 5, 2012 08:24 AM JPMorgan Downgrades Sanofi-Aventis (SNY) to Neutral

Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman

Dec 13, 2011 10:55 AM Canaccord Genuity Morning Coffee on Berkshire Hathaway (BRK.A): Read Barron's?

Nov 8, 2011 01:17 PM Leerink Says Terminated Alliance with Lilly Opens Doors for M&A at Amylin (AMLN)

Nov 8, 2011 08:43 AM Collins Stewart Downgrades Sanofi-Aventis (SNY) to Sell

Sep 20, 2011 08:10 AM Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); FDA Approves Amphastar’s Long Forgotten ANDA for Generic Lovenox

Sep 19, 2011 04:00 PM Leerink Swann Cuts Valuation on Momenta Pharmaceuticals (MNTA), Competition Increases

Sep 16, 2011 11:44 AM William Blair Initiates Research Coverage on MDVN, OGXI & DNDN: Three Companies in Prostate Cancer Treatment Space

Sep 9, 2011 08:16 AM Credit Suisse Downgrades Sanofi-Aventis (SNY) to Neutral

Jul 8, 2011 07:44 AM Bernstein Upgrades Sanofi-Aventis (SNY) to Outperform

May 12, 2011 02:19 PM Barclays on Global Pharmaceuticals: Global Therapeutic Conference Preview: Multiple Sclerosis

May 4, 2011 07:31 AM BofA/Merrill Lynch Upgrades Sanofi-Aventis (SNY) to Buy

Apr 14, 2011 07:54 AM Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); TEVA Comes Through With Allegra OTC Approval, “In Numbers” but Should Provide Additional Fuel

Apr 14, 2011 07:52 AM Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging

Apr 13, 2011 01:03 PM Barclays Reiterates an 'Overweight' on Regeneron Pharma (REGN); Sticking with VTE Ahead of CATT Data

Mar 23, 2011 12:45 PM Barclays Maintains an 'Overweight' on Merck (MRK); Model Update: Termination of Animal Health JV

Mar 23, 2011 10:37 AM Canaccord Genuity Morning Coffee on Merck & Co. (MRK) and Sanofi-Aventis (SNY): So Long, Farewell, Au Revoir

Mar 7, 2011 02:16 PM Barclays on Healthcare Services: Weekly Flu Clues Review

Mar 1, 2011 12:32 PM UBS Upgrades Sanofi-Aventis (SNY) to Buy, Downgrades AstraZeneca (AZN) to Neutral

Feb 18, 2011 10:00 AM Jefferies Cuts Estimate & Raises Price Target on BioMarin Pharmaceutical (BMRN), Maintains Buy Rating

Feb 17, 2011 10:34 AM Canaccord Genuity Morning Coffee on Sanofi-Aventis (SNY) and Genzyme (GENZ): An Extra $5 Will Help The Medicine Go Down

Feb 17, 2011 08:22 AM Jefferies Downgrades Genzyme (GENZ) to Hold, Lowers EPS Estimates For FY11 & FY12

Feb 17, 2011 08:22 AM Morgan Joseph Downgrades Genzyme (GENZ) to Hold; To be Acquired for $74 Plus CVRs

Jan 31, 2011 10:19 AM Canaccord Genuity Morning Coffee on Immunogen (IMGN): Not So Much

Nov 30, 2010 08:38 AM Ticonderoga Maintains a 'Neutral' on Evercore Partners (EVR); Dynegy Breakdown Highlights "Key Deal" Risk for EVR

Nov 9, 2010 11:16 AM Canaccord Genuity Maintains a 'Buy' on Amicus Therapeutics (FOLD); Rolling Out New Amigal Trials With GSK's Support

Oct 4, 2010 07:34 AM Soleil Securities Maintains a 'Buy' Rating on Hospira (HSP); We See Upside on Taxotere, Option Value on Gemzar

Oct 1, 2010 01:33 PM Barclays Maintains an 'Equalweight' Rating on Covance (CVD); Thoughts on Sanofi-Aventis Deal

Back to SNY Stock Lookup